Aisling Barry(@aislingbarryro) 's Twitter Profile Photo

Thrilled and excited to have liver SBRT available Cork University Hospitals!
⭐️1st public hospital in the country to have this fantastic treatment option for patients with
Huge amount of work by this multi-d group couldn’t be more proud HSE Ireland NCCP Orla McKivitt (Cashman)

Thrilled and excited to have liver SBRT available @CUH_Cork!
⭐️1st public hospital in the country to have this fantastic treatment option for patients with #livercancer 
Huge amount of work by this multi-d group couldn’t be more proud @HSELive @hseNCCP @OrlaCashman
account_circle
Nature Medicine(@NatureMedicine) 's Twitter Profile Photo

NEW online & being presented this afternoon at the poster session: A personalised DNA + anti-PD1 was safe & led to encouraging clinical efficacy in patients with advanced Mark Yarchoan Johns Hopkins Kimmel Cancer Center Niranjan Sardesai nature.com/articles/s4159…

account_circle
UT Southwestern Medical Center(@UTSWMedCenter) 's Twitter Profile Photo

A study shows drug targeting protein boosts immunotherapy response in patients. Researcher David Hsieh, M.D., says the approach shows promise in improving the success of cancer immunotherapies. bit.ly/3UIRqIw

account_circle
AIG Hospitals(@AIGHospitals) 's Twitter Profile Photo

An evening dedicated towards understanding the latest advancements in management of Hepatocellular Carcinoma ( ) at the . We were thrilled to have Dr. Amit G Singal (Amit G Singal) sharing insights about plus in treatment of .

An evening dedicated towards understanding the latest advancements in management of Hepatocellular Carcinoma (#HCC) at the #AIGHospitals. We were thrilled to have Dr. Amit G Singal (@docamitgs) sharing insights about #atezolizumab plus #bevacizumab in treatment of #LiverCancer.
account_circle
Dr Ashish Kumar(@DrAshish_Kumar) 's Twitter Profile Photo

Thrilled to welcome today Prof. Arndt Vogel, a leading expert in oncology, to Sir Ganga Ram Hospital today! He shared cutting-edge insights on systemic treatments for and , focusing on immunotherapy and recent trials. A truly enlightening session! Arndt Vogel

Thrilled to welcome today Prof. Arndt Vogel, a leading expert in oncology, to @sgrhindia today! He shared cutting-edge insights on systemic treatments for #HCC and #BTC, focusing on immunotherapy and recent trials. A truly enlightening session! #LiverCancer #Cancer @ArndtVogel
account_circle
Sidney Kimmel Cancer Center – Jefferson Health(@KimmelCancerCtr) 's Twitter Profile Photo

🎉 Congratulations to Dr. Hien Dang, who has been named the J. Wallace Davis and Gail G. Davis Chair in Surgery @JEFFSurgery! 👏

Hien Dang, PhD studies , which is the third leading cause of cancer death worldwide, and can be difficult to treat.

🎉 Congratulations to Dr. Hien Dang, who has been named the J. Wallace Davis and Gail G. Davis Chair in Surgery @JEFFSurgery! 👏

@Danglab1 studies #livercancer, which is the third leading cause of cancer death worldwide, and can be difficult to treat.
account_circle
Blue Faery(@BlueFaeryLiver) 's Twitter Profile Photo

Asian Americans have the second highest number of new liver cancer patients. Learn why it is so important to by joining our in-person community event!

Register here: vist.ly/365i5

Asian Americans have the second highest number of new liver cancer patients. Learn why it is so important to #LoveYourLiver by joining our in-person community event!

Register here: vist.ly/365i5

#AAPIMonth #livercancer #liverdisease #liverhealth
account_circle
Yale School of Medicine(@YaleMed) 's Twitter Profile Photo

In a new study, a Yale Pathology team has identified a possible target for -induced . Researchers say inhibiting a molecule called fatty acid binding protein 5 (FABP5) could block progression in many cases. brnw.ch/21wJd6Q

In a new study, a @yalepathology team has identified a possible target for #treating #obesity-induced #livercancer. Researchers say inhibiting a molecule called fatty acid binding protein 5 (FABP5) could block #tumor progression in many cases. #medtwitter brnw.ch/21wJd6Q
account_circle
Nature Reviews Gastroenterology & Hepatology(@NatRevGastroHep) 's Twitter Profile Photo

has high incidence and mortality globally. AI has advanced rapidly and has the potential to improve cancer care. Find out more in this Perspective by Jakob Nikolas Kather & colleagues
rdcu.be/dFbBF

#Livercancer has high incidence and mortality globally. AI has advanced rapidly and has the potential to improve cancer care. Find out more in this Perspective by @jnkath & colleagues
rdcu.be/dFbBF

#WorldLiverDay
account_circle
Dr G V Rao(@gvraoaig) 's Twitter Profile Photo

Redefining Treatment Landscape in Hepatocellular Carcinoma (HCC), a dedicated symposium to learn and discuss about newer advancements in the management of Liver Cancer. Tomorrow, 10th May from 6 pm onwards at the AIG Hospitals

Redefining Treatment Landscape in Hepatocellular Carcinoma (HCC), a dedicated symposium to learn and discuss about newer advancements in the management of Liver Cancer. Tomorrow, 10th May from 6 pm onwards at the AIG Hospitals  #AIGHospitals #LiverCancer #HCC
account_circle
XingXing Zang(@xingxing_zang) 's Twitter Profile Photo

We spent 7 years to create a new type of CAR-T: TOP CAR, demonstrating high effectiveness against solid tumors. In the near future, we hope to start TOP CAR clinical trials in hard-to-treat cancers of , etc

account_circle
Liver Transplantation Journal (LTxJournal)(@LTxJournal) 's Twitter Profile Photo

Association between bridging therapy & post- outcomes in patients with hepatocellular carcinoma within Milan criteria: A systematic review & meta-analysis by Ashwini Arvind (she/her) et al

journals.lww.com/lt/abstract/99…

Association between bridging therapy & post- #transplant outcomes in patients with hepatocellular carcinoma within Milan criteria: A systematic review & meta-analysis by @dr_ash_arvind et al

journals.lww.com/lt/abstract/99…

#HCC #livercancer #livertwitter
account_circle
Nature Reviews Gastroenterology & Hepatology(@NatRevGastroHep) 's Twitter Profile Photo

Chronic virus infection affects ~296 million people worldwide & is the leading cause of & globally

This REVIEW examines global burden of & calls for action to eliminate HBV as a public health threat rdcu.be/dFbFL

Chronic #hepatitisB virus infection affects ~296 million  people worldwide & is the leading cause of #cirrhosis & #livercancer globally

This REVIEW examines global burden of #HBV & calls for action to eliminate HBV as a public health threat rdcu.be/dFbFL
#WorldLiverDay
account_circle